Medical Marijuana is the medical use of Cannabis sativa or Cannabis indica plant to relieve symptoms of or treat diseases and conditions. Cannabinoids are chemicals related to delta-9-tetrahydrocannabinol (THC), Marijuana’s main mind-altering ingredient that makes people “high”. The Marijuana plant contains more than 100 cannabinoids.
DelveInsight offers a brand new inclusion to its newsletter edition that centers around the Medical Marijuana market. The newsletter encompasses the complete Medical Marijuana market landscape, constituting current & ongoing clinical trials, pipeline therapies, marketed and upcoming, novel drugs in the Medical Marijuana therapeutic area that are anticipated to transform the Medical Marijuana market in the coming years. Find out more about the details of Medical Marijuana epidemiological insights, recent news, and happenings, mergers and collaborations, major pharmaceuticals involved, licensing deals along with events and top-level conferences expected to occur in the Medical Marijuana landscape.
Subscribe to our mailing list and stay informed about all the latest developments in the Psychoactive Drugs treatment market. Join our Newsletter series and get rich insights delivered every week to you.
Gain access to the newsletter by filling up the form to the right. Download our Newsletter by simply filling up the form towards the right and stay in touch to learn more about our fresh offerings and services.
Stay tuned for more.
Also, have a look at the Conditions Medical Marijuana is Anticipated to be Prescribed
Know more about What's covered:
- Indication overview
- Medical Marijuana Toxic Effects
- Therapeutic Applications
- Current Medical Marijuana Treatment Regimen
- Medical Marijuana Epidemiological Trends
- R&D in the field
- Top conferences
- News Flash
- Recent Research Activities
- Support from International organizations
- Medical Marijuana Market Insights
- Medical Marijuana Market Dynamics
- Collaborations and deals in the domain